NVO logo

Novo Nordisk A/S (NVO) Operating profit

annual operating profit:

$18.62B+$3.73B(+25.03%)
December 31, 2024

Summary

  • As of today (April 12, 2025), NVO annual operating income is $18.62 billion, with the most recent change of +$3.73 billion (+25.03%) on December 31, 2024.
  • During the last 3 years, NVO annual operating profit has risen by +$9.29 billion (+99.55%).
  • NVO annual operating profit is now at all-time high.

Performance

NVO Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

quarterly operating profit:

$5.25B+$264.84M(+5.31%)
December 31, 2024

Summary

  • As of today (April 12, 2025), NVO quarterly operating income is $5.25 billion, with the most recent change of +$264.84 million (+5.31%) on December 31, 2024.
  • Over the past year, NVO quarterly operating profit has stayed the same.
  • NVO quarterly operating profit is now at all-time high.

Performance

NVO quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

TTM operating profit:

$18.62B+$1.39B(+8.05%)
December 31, 2024

Summary

  • As of today (April 12, 2025), NVO TTM operating income is $18.62 billion, with the most recent change of +$1.39 billion (+8.05%) on December 31, 2024.
  • Over the past year, NVO TTM operating profit has stayed the same.
  • NVO TTM operating profit is now at all-time high.

Performance

NVO TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

NVO Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.0%0.0%0.0%
3 y3 years+99.5%+150.3%+99.3%
5 y5 years+136.6%+198.2%+129.4%

NVO Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+99.5%at high+123.5%at high+90.0%
5 y5-yearat high+136.6%at high+193.2%at high+129.4%
alltimeall timeat high>+9999.0%at high+386.1%at high+2602.8%

Novo Nordisk A/S Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$18.62B(+25.0%)
$5.25B(+5.3%)
$18.62B(+8.0%)
Sep 2024
-
$4.98B(+33.2%)
$17.23B(+6.5%)
Jun 2024
-
$3.74B(-19.3%)
$16.18B(+1.6%)
Mar 2024
-
$4.64B(+20.1%)
$15.92B(+6.9%)
Dec 2023
$14.89B(+40.4%)
$3.86B(-1.7%)
$14.89B(+11.3%)
Sep 2023
-
$3.93B(+12.6%)
$13.38B(+9.8%)
Jun 2023
-
$3.49B(-3.2%)
$12.18B(+7.6%)
Mar 2023
-
$3.61B(+53.5%)
$11.32B(+6.8%)
Dec 2022
$10.60B(+13.6%)
$2.35B(-14.0%)
$10.60B(+2.4%)
Sep 2022
-
$2.73B(+3.8%)
$10.35B(+3.1%)
Jun 2022
-
$2.63B(-8.8%)
$10.04B(+2.4%)
Mar 2022
-
$2.89B(+37.7%)
$9.80B(+4.9%)
Dec 2021
$9.33B(+12.5%)
$2.10B(-13.3%)
$9.34B(+3.4%)
Sep 2021
-
$2.42B(+0.9%)
$9.03B(+4.7%)
Jun 2021
-
$2.40B(-1.4%)
$8.63B(+4.2%)
Mar 2021
-
$2.43B(+35.6%)
$8.27B(+0.3%)
Dec 2020
$8.29B(+5.4%)
$1.79B(-11.0%)
$8.25B(+0.4%)
Sep 2020
-
$2.01B(-1.5%)
$8.22B(+1.1%)
Jun 2020
-
$2.04B(-15.1%)
$8.13B(+0.2%)
Mar 2020
-
$2.41B(+36.7%)
$8.12B(+3.0%)
Dec 2019
$7.87B(+5.1%)
$1.76B(-8.5%)
$7.88B(+1.4%)
Sep 2019
-
$1.92B(-4.9%)
$7.76B(+1.1%)
Jun 2019
-
$2.02B(-6.6%)
$7.68B(+0.9%)
Mar 2019
-
$2.17B(+31.5%)
$7.61B(+1.5%)
Dec 2018
$7.48B(+0.4%)
$1.65B(-10.5%)
$7.50B(+0.8%)
Sep 2018
-
$1.84B(-5.8%)
$7.44B(-0.8%)
Jun 2018
-
$1.96B(-4.8%)
$7.50B(-0.3%)
Mar 2018
-
$2.05B(+29.2%)
$7.53B(+1.6%)
Dec 2017
$7.45B(+3.5%)
$1.59B(-16.5%)
$7.40B(-0.5%)
Sep 2017
-
$1.90B(-3.8%)
$7.44B(+0.6%)
Jun 2017
-
$1.98B(+2.4%)
$7.40B(+1.1%)
Mar 2017
-
$1.93B(+18.9%)
$7.32B(+1.6%)
Dec 2016
$7.20B(-2.1%)
$1.62B(-12.8%)
$7.20B(-0.1%)
Sep 2016
-
$1.86B(-1.8%)
$7.21B(+1.1%)
Jun 2016
-
$1.90B(+4.2%)
$7.13B(+0.7%)
Mar 2016
-
$1.82B(+11.6%)
$7.08B(-3.8%)
Dec 2015
$7.36B(+19.6%)
$1.63B(-8.6%)
$7.36B(+1.3%)
Sep 2015
-
$1.78B(-3.5%)
$7.27B(+3.7%)
Jun 2015
-
$1.85B(-11.9%)
$7.01B(+3.6%)
Mar 2015
-
$2.10B(+36.6%)
$6.76B(+10.2%)
Dec 2014
$6.15B(+9.7%)
$1.54B(+0.8%)
$6.14B(+3.3%)
Sep 2014
-
$1.52B(-5.1%)
$5.95B(+1.8%)
Jun 2014
-
$1.60B(+8.8%)
$5.84B(+1.8%)
Mar 2014
-
$1.47B(+9.9%)
$5.74B(+2.4%)
Dec 2013
$5.61B(+10.2%)
$1.34B(-5.5%)
$5.60B(+0.5%)
Sep 2013
-
$1.42B(-5.6%)
$5.58B(+1.8%)
Jun 2013
-
$1.50B(+12.4%)
$5.48B(+3.4%)
Mar 2013
-
$1.34B(+1.6%)
$5.30B(+4.2%)
Dec 2012
$5.09B(+21.8%)
$1.32B(-0.3%)
$5.08B(+3.1%)
Sep 2012
-
$1.32B(-0.1%)
$4.93B(+5.9%)
Jun 2012
-
$1.32B(+17.4%)
$4.66B(+7.0%)
Mar 2012
-
$1.13B(-3.3%)
$4.35B(+3.8%)
Dec 2011
$4.18B(+24.3%)
$1.16B(+11.5%)
$4.19B(+9.8%)
Sep 2011
-
$1.04B(+2.8%)
$3.82B(+4.3%)
Jun 2011
-
$1.02B(+5.1%)
$3.66B(+4.4%)
Mar 2011
-
$966.88M(+22.2%)
$3.51B(+5.8%)
Dec 2010
$3.36B(+17.7%)
$791.01M(-10.9%)
$3.31B(+0.2%)
Sep 2010
-
$888.25M(+3.1%)
$3.31B(+5.4%)
Jun 2010
-
$861.19M(+11.4%)
$3.14B(+3.7%)
Mar 2010
-
$773.15M(-1.6%)
$3.03B(+3.6%)
Dec 2009
$2.86B(+16.9%)
$785.40M(+9.1%)
$2.92B(+6.7%)
Sep 2009
-
$719.57M(-3.9%)
$2.74B(+1.9%)
Jun 2009
-
$748.42M(+12.1%)
$2.69B(+6.0%)
Mar 2009
-
$667.67M(+10.8%)
$2.54B(+4.1%)
Dec 2008
$2.44B(+48.4%)
$602.60M(-9.9%)
$2.44B(+18.4%)
Sep 2008
-
$668.90M(+12.1%)
$2.06B(+9.2%)
Jun 2008
-
$596.69M(+4.9%)
$1.88B(+4.9%)
Mar 2008
-
$568.66M(+154.2%)
$1.80B(+9.8%)
Dec 2007
$1.65B(+7.3%)
$223.68M(-54.8%)
$1.64B(-7.9%)
Sep 2007
-
$494.88M(-2.7%)
$1.78B(+4.0%)
Jun 2007
-
$508.61M(+24.6%)
$1.71B(+3.9%)
Mar 2007
-
$408.19M(+12.2%)
$1.64B(+6.7%)
Dec 2006
$1.54B(+13.9%)
$363.90M(-14.8%)
$1.54B(+4.0%)
Sep 2006
-
$426.95M(-3.8%)
$1.48B(+3.5%)
Jun 2006
-
$443.88M(+45.7%)
$1.43B(+3.4%)
Mar 2006
-
$304.64M(-0.2%)
$1.38B(+2.8%)
Dec 2005
$1.35B(+14.7%)
$305.28M(-19.1%)
$1.35B(-2.2%)
Sep 2005
-
$377.50M(-4.8%)
$1.38B(+7.1%)
Jun 2005
-
$396.48M(+48.8%)
$1.29B(+7.6%)
Mar 2005
-
$266.44M(-20.6%)
$1.19B(+1.1%)
Dec 2004
$1.18B
$335.65M(+17.2%)
$1.18B(-258.8%)
Sep 2004
-
$286.45M(-6.4%)
-$743.79M(+327.1%)
DateAnnualQuarterlyTTM
Jun 2004
-
$305.95M(+20.8%)
-$174.15M(-148.5%)
Mar 2004
-
$253.37M(-115.9%)
$358.96M(-57.5%)
Dec 2003
$973.92M(+28.1%)
-$1.59B(-285.7%)
$844.54M(+12.6%)
Sep 2003
-
$856.09M(+2.0%)
$750.05M(+0.3%)
Jun 2003
-
$839.06M(+13.5%)
$747.75M(+33.1%)
Mar 2003
-
$738.95M(-143.9%)
$561.66M(+5.4%)
Dec 2002
$760.15M(+13.0%)
-$1.68B(-297.2%)
$532.93M(-35.0%)
Sep 2002
-
$853.80M(+30.8%)
$820.23M(+7.5%)
Jun 2002
-
$652.97M(-8.1%)
$763.23M(-2.5%)
Mar 2002
-
$710.22M(-150.8%)
$782.93M(+6.6%)
Dec 2001
$672.69M(+27.9%)
-$1.40B(-275.3%)
$734.28M(+64.1%)
Sep 2001
-
$796.80M(+18.5%)
$447.56M(-70.4%)
Jun 2001
-
$672.68M(+1.7%)
$1.51B(-8.4%)
Mar 2001
-
$661.56M(-139.3%)
$1.65B(-4.4%)
Dec 2000
$525.93M(+25.6%)
-$1.68B(-190.4%)
$1.73B(+3.2%)
Sep 2000
-
$1.86B(+129.8%)
$1.67B(+164.8%)
Jun 2000
-
$810.58M(+9.9%)
$631.91M(+18.0%)
Mar 2000
-
$737.25M(-142.4%)
$535.67M(+7.6%)
Dec 1999
$418.81M(+95.5%)
-$1.74B(-311.5%)
$497.68M(+24.2%)
Sep 1999
-
$821.66M(+15.0%)
$400.56M(+21.5%)
Jun 1999
-
$714.35M(+2.2%)
$329.62M(+16.3%)
Mar 1999
-
$699.25M(-138.1%)
$283.42M(+49.8%)
Dec 1998
$214.19M(-39.5%)
-$1.83B(-344.4%)
$189.17M(-64.5%)
Sep 1998
-
$750.72M(+12.4%)
$533.53M(+30.1%)
Jun 1998
-
$668.15M(+10.4%)
$410.22M(+9.7%)
Mar 1998
-
$605.00M(-140.6%)
$373.83M(+8.7%)
Dec 1997
$354.00M(+3.6%)
-$1.49B(-337.5%)
$343.90M(-1.1%)
Sep 1997
-
$627.41M(-0.7%)
$347.59M(-2.2%)
Jun 1997
-
$631.76M(+9.9%)
$355.50M(+10.7%)
Mar 1997
-
$575.07M(-138.7%)
$321.20M(-8.5%)
Dec 1996
$341.54M(+2.1%)
-$1.49B(-334.0%)
$351.00M(+13.0%)
Sep 1996
-
$635.32M(+6.3%)
$310.67M(+22.2%)
Jun 1996
-
$597.46M(-1.2%)
$254.25M(-17.8%)
Mar 1996
-
$604.87M(-139.6%)
$309.26M(+10.6%)
Dec 1995
$334.50M(+15.3%)
-$1.53B(-363.8%)
$279.55M(-39.6%)
Sep 1995
-
$578.90M(-11.3%)
$462.93M(+7.2%)
Jun 1995
-
$652.47M(+13.4%)
$431.98M(+41.5%)
Mar 1995
-
$575.16M(-142.8%)
$305.32M(+57.9%)
Dec 1994
$290.00M(-3.4%)
-$1.34B(-345.2%)
$193.31M(-61.2%)
Sep 1994
-
$547.95M(+4.2%)
$498.12M(+20.1%)
Jun 1994
-
$525.81M(+13.5%)
$414.84M(+11.2%)
Mar 1994
-
$463.15M(-144.6%)
$373.05M(+13.9%)
Dec 1993
$300.23M(+56.1%)
-$1.04B(-323.6%)
$327.44M(+42.2%)
Sep 1993
-
$464.66M(-4.0%)
$230.21M(+4.7%)
Jun 1993
-
$484.02M(+15.9%)
$219.90M(+17.9%)
Mar 1993
-
$417.53M(-136.8%)
$186.47M(-3.2%)
Dec 1992
$192.36M(-12.6%)
-$1.14B(-350.0%)
$192.69M(-58.0%)
Sep 1992
-
$454.35M(+0.8%)
$458.91M(+27.5%)
Jun 1992
-
$450.60M(+6.3%)
$359.94M(+45.3%)
Mar 1992
-
$423.75M(-148.7%)
$247.65M(+17.7%)
Dec 1991
$220.07M(+29.1%)
-$869.78M(-344.7%)
$210.43M(-4.3%)
Sep 1991
-
$355.38M(+5.1%)
$219.95M(+10.7%)
Jun 1991
-
$338.30M(-12.5%)
$198.62M(+11.5%)
Mar 1991
-
$386.54M(-144.9%)
$178.09M(+99.9%)
Dec 1990
$170.48M(+18.5%)
-$860.27M(-357.5%)
$89.08M(-72.2%)
Sep 1990
-
$334.06M(+5.1%)
$320.60M(+45.5%)
Jun 1990
-
$317.76M(+6.8%)
$220.29M(+61.6%)
Mar 1990
-
$297.53M(-147.3%)
$136.35M(+19.6%)
Dec 1989
$143.85M(+3.2%)
-$628.74M(-369.0%)
$113.96M(-61.5%)
Sep 1989
-
$233.75M(-0.0%)
$295.66M(+19.7%)
Jun 1989
-
$233.82M(-15.0%)
$247.03M(+9.3%)
Mar 1989
-
$275.14M(-161.5%)
$226.03M(+66.2%)
Dec 1988
$139.39M(+47.1%)
-$447.04M(-341.5%)
$136.02M(+8.2%)
Sep 1988
-
$185.12M(-13.0%)
$125.67M(+3.7%)
Jun 1988
-
$212.81M(+15.0%)
$121.19M(+51.2%)
Mar 1988
-
$185.13M(-140.5%)
$80.13M(+12.1%)
Dec 1987
$94.76M(+14.3%)
-$457.39M(-353.2%)
$71.49M(-64.6%)
Sep 1987
-
$180.64M(+5.2%)
$202.13M(+34.0%)
Jun 1987
-
$171.75M(-2.7%)
$150.89M(+33.6%)
Mar 1987
-
$176.49M(-154.0%)
$112.91M(+105.3%)
Dec 1986
$82.91M(+18.9%)
-$326.75M(-352.5%)
$55.00M(-56.7%)
Sep 1986
-
$129.40M(-3.3%)
$126.97M(+35.8%)
Jun 1986
-
$133.77M(+12.8%)
$93.51M(+70.1%)
Mar 1986
-
$118.58M(-146.5%)
$54.98M(+90.2%)
Dec 1985
$69.75M(+26.2%)
-$254.79M(-365.6%)
$28.90M(-65.6%)
Sep 1985
-
$95.94M(+0.7%)
$83.91M(+5.5%)
Jun 1985
-
$95.24M(+3.0%)
$79.51M(+5.4%)
Mar 1985
-
$92.51M(-146.3%)
$75.44M(+0.5%)
Dec 1984
$55.29M
-$199.77M(-318.2%)
$75.07M(-72.7%)
Sep 1984
-
$91.54M(+0.4%)
$274.84M(+49.9%)
Jun 1984
-
$91.16M(-1.1%)
$183.30M(+98.9%)
Mar 1984
-
$92.14M
$92.14M

FAQ

  • What is Novo Nordisk A/S annual operating income?
  • What is the all time high annual operating profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual operating profit year-on-year change?
  • What is Novo Nordisk A/S quarterly operating income?
  • What is the all time high quarterly operating profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly operating profit year-on-year change?
  • What is Novo Nordisk A/S TTM operating income?
  • What is the all time high TTM operating profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM operating profit year-on-year change?

What is Novo Nordisk A/S annual operating income?

The current annual operating profit of NVO is $18.62B

What is the all time high annual operating profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual operating income is $18.62B

What is Novo Nordisk A/S annual operating profit year-on-year change?

Over the past year, NVO annual operating income has changed by +$3.73B (+25.03%)

What is Novo Nordisk A/S quarterly operating income?

The current quarterly operating profit of NVO is $5.25B

What is the all time high quarterly operating profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly operating income is $5.25B

What is Novo Nordisk A/S quarterly operating profit year-on-year change?

Over the past year, NVO quarterly operating income has changed by $0.00 (0.00%)

What is Novo Nordisk A/S TTM operating income?

The current TTM operating profit of NVO is $18.62B

What is the all time high TTM operating profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM operating income is $18.62B

What is Novo Nordisk A/S TTM operating profit year-on-year change?

Over the past year, NVO TTM operating income has changed by $0.00 (0.00%)
On this page